Concluding Remarks: Optimal Treatment for Women With Ovarian Cancer

References 

1. National Cancer Institute: Ovarian Cancer (PDQ): Prevention. Available at: http://www.cancer.gov/cancertopics/pdq/screening/ovarian (accessed August 24, 2006)
2. National Cancer Institute: Ovarian Cancer (PDQ): Screening. Available at: http://www.cancer.gov/cancertopics/pdq/prevention/ovarian (accessed August 24, 2006)
3. Goff BA, Mandel LS, Melancon CH, et al. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA. 2004;291:2705–2712
   • CrossRef
4. Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol. 2002;20:1248–1259
   • MEDLINE
   • CrossRef
5. Munoz KA, Harlan LC, Trimble EL. Patterns of care for women with ovarian cancer in the United States. J Clin Oncol. 1997;15:3408–3415
   • MEDLINE
6. du Bois A, Quinn M, Thigpen T, et al. 2004 consensus statement on the management of ovarian cancer; final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference. Ann Oncol. 2005;16(suppl 8):viii7–viii12
   • CrossRef
7. National Cancer Institute: Cancer Therapy Evaluation Program (CETP): NCI Clinical Announcement on Intraperitoneal Chemotherapy in Ovarian Cancer (January 5, 2006) Available at: http://ctep.cancer.gov/highlights/ovarian.html. (accessed August 24, 2006)
8. Gynecologic Oncology Group. Available at: http://www.gog.org (accessed August 24, 2006)
9. National Cancer Policy Board. Improving Palliative Care for Cancer. Washington, DC: National Academy Press; 2001;